Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1530107

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1530107

North America AREDS 2 Supplements Market Size, Share & Trends Analysis Report By Product (Capsules, Tablets, Soft Gels), By Distribution Channel, By Country, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 78 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

North America AREDS 2 Supplements Market Growth & Trends:

The North America AREDS 2 supplements market size is expected to reach USD 423.1 million by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The North America AREDS 2 supplements market is experiencing significant growth, driven by a combination of health trends, demographic shifts, and technological advancements. At the forefront of this growth is the increasing prevalence of chronic eye diseases, particularly Age-related Macular Degeneration (AMD). The AREDS 2 formula, which includes specific dosages of zinc, lutein, zeaxanthin, and various vitamins, has shown promising results in reducing the risk of disease progression and preserving functional vision, making it a go-to choice for those at risk or already affected by AMD.

Awareness about eye health and the benefits of supplements like AREDS 2 has grown substantially in recent years. This increased awareness, coupled with the widespread availability of these supplements over-the-counter and through various sales channels, including online platforms, has significantly boosted market growth. The COVID-19 pandemic has further accelerated this trend, with a notable increase in internet sales of eye health supplements. This shift in consumer behavior has made these products more accessible to a broader audience, contributing to the market's expansion.

Product innovation and new launches are playing a crucial role in driving the market forward. Companies in the sector are continuously developing new formulations to meet evolving consumer needs. For instance, in May 2024, EyePromise, a leading nutraceutical company specializing in eye health, unveiled the latest enhancements to its extensive nutritional program tailored for eyecare practices. Focused on innovation and enhancement, EyePromise has enhanced its AREDS 2-based products. These scientifically backed formulas will now be branded as Macular Health and Macular Health Complete.

North America AREDS 2 Supplements Market Report Highlights:

  • North America AREDS 2 soft gels market accounted for a share of over 49% of the North Americas revenues in 2023. This innovative two-in-one soft gel addresses the needs of the aging population who are managing both age-related macular degeneration (AMD) and heart disease, offering a convenient solution that simplifies their supplement regimen. Leading companies are enhancing their product offerings with soft gels, which are favored for their ease of swallowing, precise dosage, and better absorption
  • The sales of North America AREDS 2 supplements through online distribution channels are projected to grow at a CAGR of 6.9% from 2024 to 2030. AREDS 2 supplements offered by most companies are available through Amazon, providing an online shopping option for those who prefer digital convenience. Companies prefer a multi-channel approach to enhance product availability and meet the diverse purchasing preferences of North American consumers. The COVID-19 pandemic further accelerated the shift towards online shopping as consumers prioritize health and safety
  • The AREDS 2 supplements market in the U.S. is projected to grow at a CAGR of 6.3% from 2024 to 2030. The market for AREDS 2 supplements in the U.S. is primarily driven by the growing awareness of age-related macular degeneration (AMD) and the desire for preventative measures among the aging population. AMD is a leading cause of vision loss among older adults, making it a significant public health concern
Product Code: GVR-4-68040-336-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segmental Outlook
  • 2.3. Regional Outlook

Chapter 3. North America AREDS 2 Supplements Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. North America AREDS 2 Supplements Market: Consumer Behavior Analysis

  • 4.1. Demographic Analysis
  • 4.2. Consumer Trends & Preferences
  • 4.3. Factors Influencing Buying Behavior
  • 4.4. Consumer Service Adoption Trends
  • 4.5. Key Observations & Findings

Chapter 5. North America AREDS 2 Supplements Market: Product Estimates & Trend Analysis

  • 5.1. Product Movement Analysis & Market Share, 2023 & 2030
  • 5.2. Capsules
    • 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3. Tablets
    • 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Soft gels
    • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. North America AREDS 2 Supplements Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Movement Analysis & Market Share, 2023 & 2030
  • 6.2. Pharmacies
    • 6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. North America AREDS 2 Supplements Market: Country Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2023 & 2030
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key country dynamics
      • 7.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key country dynamics
      • 7.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key country dynamics
      • 7.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2023 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. Company Profiles
    • 8.9.1. Bausch + Lomb
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Portfolios
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Alcon Inc.
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Portfolios
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. Nature Made (Pharmavite LLC)
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Portfolios
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. Viteyes (Vitamin Health, Inc.)
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Portfolios
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. EyePromise (ZeaVision, LLC)
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Portfolios
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. MacuHealth
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Portfolios
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. NATURELO Premium Supplements, LLC
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Portfolios
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. VISTA
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Portfolios
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. Codeage LLC
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Portfolios
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. NutraChamps Inc.
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Portfolios
      • 8.9.10.4. Strategic Initiatives
Product Code: GVR-4-68040-336-2

List of Tables

  • Table 1 North America AREDS 2 supplements market - Driving factor market analysis
  • Table 2 North America AREDS 2 supplements market - Restraint analysis
  • Table 3 North America AREDS 2 supplements market estimates & forecast, by product (USD Million)
  • Table 4 North America AREDS 2 supplements market estimates & forecast, by distribution channel (USD Million)
  • Table 5 U.S. macro-economic outlay
  • Table 6 Canada macro-economic outlay
  • Table 7 Mexico macro-economic outlay
  • Table 8 Recent developments & impact analysis, by key market participants
  • Table 9 Company market share, 2023
  • Table 10 Company heat map analysis
  • Table 11 Key companies involved in product launches
  • Table 12 Key companies involved in partnerships
  • Table 13 Key companies involved in other strategic initiatives

List of Figures

  • Fig. 1 North America AREDS 2 supplements market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 North America AREDS 2 supplements market snapshot
  • Fig. 7 Segment snapshot
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Global dietary supplements market, 2023 (USD Million)
  • Fig. 10 North America AREDS 2 supplements market - Value chain analysis
  • Fig. 11 North America AREDS 2 supplements market - Profit-margin analysis
  • Fig. 12 North America AREDS 2 supplements market dynamics
  • Fig. 13 North America AREDS 2 supplements market: Porter's Five Force Analysis
  • Fig. 14 Demographic analysis by gender in North America, 2023
  • Fig. 15 Demographic analysis by age in North America, 2023
  • Fig. 16 Factors influencing buying behavior
  • Fig. 17 North America AREDS 2 supplements market, by product: Key takeaways
  • Fig. 18 North America AREDS 2 supplements market, by product: Market share, 2023 & 2030
  • Fig. 19 North America AREDS 2 capsules market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 20 North America AREDS 2 tablets market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 21 North America AREDS 2 soft gels market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 22 North America other AREDS 2 supplements market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 23 North America AREDS 2 supplements market, by distribution channel: Key takeaways
  • Fig. 24 North America AREDS 2 supplements market, by distribution channel: Market share, 2023 & 2030
  • Fig. 25 North America AREDS 2 supplements market estimates & forecast, through pharmacies, 2018 - 2030 (USD Million)
  • Fig. 26 North America AREDS 2 supplements market estimates & forecast, through online channel, 2018 - 2030 (USD Million)
  • Fig. 27 North America AREDS 2 supplements market estimates & forecast, through other channels, 2018 - 2030 (USD Million)
  • Fig. 28 North America AREDS 2 Supplements market revenue, by country, 2023 & 2030 (USD Million)
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America AREDS 2 supplements market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. AREDS 2 supplements market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Canada AREDS 2 supplements market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico AREDS 2 supplements market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Key company categorization
  • Fig. 35 Company market share analysis, 2023
  • Fig. 36 Strategic framework of the North America AREDS 2 supplements market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!